Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples

Cancer Research

Volumn 57, Issue 1, 1997, Pages 18-23

  Sun, Yilong ^a   Lin, Jian ^a   Katz, Aaron E ^a   Fisher, Paul B ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER DIAGNOSIS; CELL CULTURE; DNA SEQUENCE; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MYCOPLASMA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENTIAL ANALYSIS; SOUTHERN BLOTTING; TUMOR CELL LINE;

BASE SEQUENCE; DNA, BACTERIAL; FALSE POSITIVE REACTIONS; GENETIC MARKERS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; ONCOGENES; PEPTIDE ELONGATION FACTOR 1; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031028264     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Epstein, J. I., Pizov, G., and Walsch, P. C. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer (Phila.), 71: 3582-3593, 1993.
2. Mukamel, E., Hanna, J., and deKernion, J. B. Pitfalls in preoperative staging in prostate cancer. Urology, 30: 318-323, 1987.
3. Salo, J. O., Kivisaari, L., Rannikko, S., and Lehtonen, T. J. Computerized tomography and transrectal ultrasound in the assessment of local extension of prostatic cancer before radical retropubic prostatectomy. J. Urol., 137: 435-438, 1987.
4. Lu-Yao, G. L., McLerran, D., Wasson, J., and Wennberg, J. E. An assessment of radical prostatectomy. Time trends, geographic variation and outcomes. The Prostate Patient Outcomes Research Team. J. Am. Med. Assoc., 269: 2633-2636, 1993.
5. Su, Z-z., Olsson, C. A., Zimmer, S. G., and Fisher, P. B. Transfer of a dominant-acting tumor-inducing oncogene from human prostatic carcinoma cells to cloned rat embryo fibroblast cells by DNA-transfection. Anticancer Res., 12: 297-304, 1992.
6. Liang, R., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Washington DC), 257: 967-997, 1992.
7. Shen, R., Su, Z-z., Olsson, C. A., and Fisher, P. B. Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc. Natl. Acad. Sci. USA, 92: 6778-6782, 1995.
8. Su, Z-z., Lin, J., Shen, R., Fisher, P. E., Goldstein, N. I., and Fisher, P. B. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1, a member of the galectin gene family. Proc. Natl. Acad. Sci. USA, 93: 7252-7257, 1996.
9. Jiang, H., and Fisher, P. B. Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially regulated during the induction of differentiation in human melanoma cells. Mol. Cell. Differ., 1: 285-299, 1993.
10. Jiang, H., Lin, J., Su, Z-z., Herlyn, M., Kerbel, R. S., Weissman, B. E., Welch, D. R., and Fisher, P. B. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene, 10: 1855-1864, 1995.
11. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
12. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, T., Fair, W. R., Samadi, S. D., Huryk, R. F., DeBlasio, A., Edwards, E. T., Wise, G. J., and Heston, W. D. W. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306-6310, 1994.
13. Noller, H. F. Ribosomal RNA and translation. Annu. Rev. Biochem., 60: 191-227, 1991.
14. Chastel, C. Links and interactions between Mycoplasmas and viruses: past confusions and present realities. Arch. Virol., 140: 811-826, 1995.
15. Cama, C., Olsson, C. A., Raffo, A. J., Perlman, H., Buttyan, R., O'Toole, K., McMahon, D., Benson, M. C., and Katz, A. E. Molecular staging of prostate cancer II: a comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153: 1373-1378, 1995.
16. Wang, M. C., Valenzuela, L. A., Murphy, G. P., and Chu, T. M. Purification of a human prostate specific antigen. Invest. Urol., 17: 159-163, 1979.
17. Watt, K. W. K., Lee, P-J., Timkulu, M., Chan, W-P., and Loor, R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA, 83: 3166-3170, 1986.
18. Tsai, S., Wear, D. J., Shih, J. W-K., and Lo, S-C. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc. Natl. Acad. Sci. USA, 92: 10197-10201, 1995.
19. Veronese, M. L., Bullrich, F., Negrini, M., and Croce, C. M. The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in tpc/hpr fusion gene. Cancer Res., 56: 728-732, 1996.
20. Shima, Z. A., Le Beau, M. M., McKeithan, T. W., Minowada, J., Showe, L. C., Mak, T. W., Minden, M. D., Rowley, J. D., and Diaz, M. O. Gene encoding the α chain of the T-cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. Proc. Natl. Acad. Sci. USA, 83: 3439-3443, 1986.
21. Crozat, A., Aman, P., Mandahl, N., and Ron, D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature (Lond.), 363: 640-641, 1993.